Literature DB >> 20194840

Critical need for international consensus on ototoxicity assessment criteria.

Edward A Neuwelt, Penelope Brock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20194840     DOI： 10.1200/JCO.2009.26.7872

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  14 in total

1.  Heat shock protein-mediated protection against Cisplatin-induced hair cell death.

Authors:  Tiffany G Baker; Soumen Roy; Carlene S Brandon; Inga K Kramarenko; Shimon P Francis; Mona Taleb; Keely M Marshall; Reto Schwendener; Fu-Shing Lee; Lisa L Cunningham
Journal:  J Assoc Res Otolaryngol       Date:  2014-09-27

Review 2.  Platinum-induced ototoxicity: a review of prevailing ototoxicity criteria.

Authors:  Sofia Waissbluth; Emilia Peleva; Sam J Daniel
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-05-31       Impact factor: 2.503

3.  Concordance between the chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma.

Authors:  Johnnie K Bass; Jie Huang; Arzu Onar-Thomas; Kay W Chang; Shaum P Bhagat; Murali Chintagumpala; Ute Bartels; Sridharan Gururangan; Tim Hassall; John A Heath; Geoffrey McCowage; Richard J Cohn; Michael J Fisher; Giles Robinson; Alberto Broniscer; Amar Gajjar; James G Gurney
Journal:  Pediatr Blood Cancer       Date:  2013-11-01       Impact factor: 3.167

4.  Clinical trials, ototoxicity grading scales and the audiologist's role in therapeutic decision making.

Authors:  Kelly A King; Carmen C Brewer
Journal:  Int J Audiol       Date:  2017-12-23       Impact factor: 2.117

5.  Ototoxicity in children with high-risk neuroblastoma: prevalence, risk factors, and concordance of grading scales--a report from the Children's Oncology Group.

Authors:  Wendy Landier; Kristin Knight; F Lennie Wong; Jin Lee; Ola Thomas; Heeyoung Kim; Susan G Kreissman; Mary Lou Schmidt; Lu Chen; Wendy B London; James G Gurney; Smita Bhatia
Journal:  J Clin Oncol       Date:  2014-01-13       Impact factor: 44.544

6.  Risk factors for cisplatin-associated ototoxicity in pediatric oncology patients.

Authors:  Allison Yancey; Michael S Harris; Akinbode Egbelakin; Jaimie Gilbert; David B Pisoni; Jamie Renbarger
Journal:  Pediatr Blood Cancer       Date:  2012-03-19       Impact factor: 3.167

Review 7.  A Review of Cisplatin-Associated Ototoxicity.

Authors:  Jessica Paken; Cyril D Govender; Mershen Pillay; Vikash Sewram
Journal:  Semin Hear       Date:  2019-04-26

8.  The role of inherited TPMT and COMT genetic variation in cisplatin-induced ototoxicity in children with cancer.

Authors:  J J Yang; J Y S Lim; J Huang; J Bass; J Wu; C Wang; J Fang; E Stewart; E H Harstead; S E; G W Robinson; W E Evans; A Pappo; J Zuo; M V Relling; A Onar-Thomas; A Gajjar; C F Stewart
Journal:  Clin Pharmacol Ther       Date:  2013-06-11       Impact factor: 6.875

Review 9.  Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale.

Authors:  Penelope R Brock; Kristin R Knight; David R Freyer; Kathleen C M Campbell; Peter S Steyger; Brian W Blakley; Shahrad R Rassekh; Kay W Chang; Brian J Fligor; Kaukab Rajput; Michael Sullivan; Edward A Neuwelt
Journal:  J Clin Oncol       Date:  2012-04-30       Impact factor: 44.544

10.  Prospective longitudinal assessment of sensorineural hearing loss with hyperfractionated radiation therapy alone in patients with average-risk medulloblastoma.

Authors:  Tejpal Gupta; Sarthak Mohanty; Sadhana Kannan; Rakesh Jalali
Journal:  Neurooncol Pract       Date:  2014-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.